Constellation Energy Corporation -- 8.2/10 -- $272.82

Constellation Energy is the largest U.S. nuclear fleet operator with ~22 GW of owned nuclear capacity (~23% of U.S. nuclear output) and the largest clean energy producer in the country. Following the January 2026 close of the Calpine acquisition ($16.4B in stock + $4.5B cash), the combined company operates ~55 GW of generation capacity spanning nuclear, natural gas, geothermal, and renewables. The company serves 2.5 million retail and business customers. CEO Joseph Dominguez has led the company since its February 2022 spin-off from Exelon, beating guidance every year since becoming public. The TMI Unit 1 restart (renamed Crane Clean Energy Center) -- an ~835 MW reactor backed by a 20-year Microsoft PPA and a $1B DOE loan -- targets a 2027 restart and would be the first-ever restart of a decommissioned U.S. nuclear reactor. Adj. Operating EPS grew from $6.28 (FY2023) to $9.39 (FY2025), a 50% cumulative increase in two years, and operating cash flow swung from ($2.5B) in FY2024 to +$4.2B in FY2025. Management guides to 20%+ base EPS CAGR through 2029 with no buyback assumed, plus a $5B share repurchase authorization.

Constellation Energy receives a composite score of 8.2/10, reflecting a high-conviction, franchise-quality business uniquely positioned at the intersection of the nuclear renaissance and AI data center buildout. The company owns irreplaceable assets (the largest U.S. nuclear fleet at ~22 GW), has a proven management team that has beaten guidance every year since its 2022 spin-off, and is now augmented by the Calpine gas/geothermal fleet (~55 GW combined).

The 20%+ base EPS CAGR through 2029 -- with no buyback assumption -- is grounded in contracted cash flows and conservative assumptions, leaving meaningful upside optionality from data center PPAs, capital allocation ($5B repurchase authorization), and the TMI/Crane restart. Adj. Operating EPS has compounded at ~22% since FY2023, and the massive CFO swing from ($2.5B) to +$4.2B confirms the inflection to sustainable free cash flow generation.

The key question for investors: At ~23.5x forward earnings on FY2026E consensus of ~$11.63, is CEG adequately discounting the duration and magnitude of the data center power demand cycle? The 34% pullback from all-time highs and 49% gap to analyst consensus targets provide an attractive entry point. Risks center on NRC approval for the Crane restart (no modern precedent), Calpine integration complexity, and political threats to nuclear PTCs under the IRA. However, the nuclear PTC floor, long-term contracted cash flows, and irreplaceable asset base provide substantial downside protection. CEG is the single best-positioned equity for the nuclear renaissance / AI power demand supertheme.

Key catalysts and monitoring points:

• Data center PPA announcements: The 147M MWh contracted/targeted pipeline includes deals not yet in consensus models. Any new PPA disclosures would be a direct catalyst for re-rating.
• TMI/Crane restart milestones: NRC inspection progress through 2026, with a 2027 restart target. This is the most binary risk -- a rejection or significant delay would be a meaningful negative. PJM interconnection study suggests full grid connection may lag to 2031.
• Calpine integration execution: Deleveraging to target credit metrics expected by end-2027. Monitor for synergy realization, purchase accounting headwinds, and commercial platform integration. Management maintained $2 accretion guidance despite higher-than-expected divestitures.
• FY2026 EPS trajectory: Guidance of $11-$12 Adj. Operating EPS includes ~$2 of Calpine accretion. Consensus at ~$11.63 (25 analysts). Track quarterly progression for beat/raise cadence.
• PJM capacity market and regulatory clarity: Trump executive order and PJM rulemaking on data center interconnection are expected catalysts for deal-making acceleration.
• Nuclear PTC / IRA political risk: Bipartisan support for nuclear is strong, but the broader IRA remains a political target. Any legislative movement on clean energy tax credits warrants close monitoring.
• Share repurchase cadence: $5B authorization is purely additive to the 20% EPS CAGR guide. Deployment pace signals management confidence.

For the full risk matrix and valuation analysis, see the Valuation page.

Concerns, Catalysts & Risks -- full analysis

Core long position -- highest conviction in the nuclear renaissance / AI power demand cycle. The forward PE (~23.5x FY2026E) is reasonable for a company guiding 20%+ base EPS CAGR through 2029 with no buyback assumed. If management delivers on the guided trajectory, the PE compresses meaningfully on FY2027-2028E earnings, making valuation a feature rather than a headwind. The 34% drawdown from all-time highs and 49% gap to analyst consensus targets provide an attractive entry point. Key position-sizing considerations: (1) NRC approval for TMI/Crane is the most binary risk with no modern precedent, (2) Calpine integration adds near-term complexity with elevated leverage until end-2027, (3) political risk to IRA nuclear PTCs is the structural tail risk, and (4) power price volatility remains a feature of the business despite hedging normalization. The irreplaceable nuclear asset base, contracted cash flows, and dominant competitive position provide durable downside protection while the data center demand cycle provides multi-year upside optionality.